Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey.

Autor: Nazareth TA; Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA. Electronic address: tara.nazareth@mnk.com., Rava AR; Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA. Electronic address: andrewrava23@gmail.com., Polyakov JL; Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA. Electronic address: Jackie.Polyakov@mnk.com., Banfe EN; Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA. Electronic address: Edward.Banfe@mnk.com., Waltrip Ii RW; Autoimmune and Rare Diseases, Mallinckrodt Pharmaceuticals, Bedminster, NJ, USA. Electronic address: Royce.Waltrip@mnk.com., Zerkowski KB; Community Development, Health Union, Philadelphia, PA, USA. Electronic address: kristine.zerkowski@health-union.com., Herbert LB; Research and Analytics, Health Union, Philadelphia, PA, USA. Electronic address: lb.herbert@health-union.com.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2018 Nov; Vol. 26, pp. 219-234. Date of Electronic Publication: 2018 Sep 07.